Erbitux 500mg Infusion

Опис товару

About Erbitux

Erbitux is a medication containing the active ingredient Cetuximab, classified as Epidermal Growth Factor Receptor Antagonist. Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE ERBITUX ® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer Locally.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Cetuximab, the active ingredient in Erbitux, belongs to the Epidermal Growth Factor Receptor Antagonist class. 1 INDICATIONS AND USAGE ERBITUX ® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer Locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. ( 1. 1 , 14. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Erbitux. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Erbitux for extended periods without medical advice.